Feb 21 Bristol-Myers Squibb Co said on
Tuesday it appointed three directors to its board in a deal with
activist investor Jana Partners LLC.
Bob Bertolini, former Bausch & Lomb CFO, Matthew Emmens,
former Vertex Pharmaceuticals Inc CEO, and Theodore Samuels, who
is on the boards of Perrigo and Stamps.com, have been added to
Bristol-Myers, which also announced a $2 billion accelerated
share repurchase program, said the appointments would
temporarily increase the size of the board to 14.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Saumyadeb